BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
Medtronic
Cerilliant
Federal Trade Commission
Dow
Queensland Health
Healthtrust
Moodys
Harvard Business School

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,288,703

« Back to Dashboard

Summary for Patent: 5,288,703
Title: Method for enhancing gut absorption
Abstract:The present invention provides a method for enhancing the gut absorption in a mammal. Specifically, gut absorption in a mammal can be enhanced by the administration of glutamine, or glutamine equivalent, in combination with one or more agents, said agents selected from the group consisting of growth hormone (GH), an agent capable of enhancing endogenous GH production, insulin like growth factor 1 (IGF-1), or an agent capable of enhancing endogenous IGF-1 production.
Inventor(s): Wilmore; Douglas (Brookline, MA)
Assignee: Brigham and Women's Hospital (Boston, MA)
Application Number:07/957,174
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,288,703

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,288,703

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 216253 ➤ Subscribe
Australia 2790692 ➤ Subscribe
Australia 661242 ➤ Subscribe
Canada 2120626 ➤ Subscribe
Germany 69232561 ➤ Subscribe
Denmark 0607278 ➤ Subscribe
European Patent Office 0607278 ➤ Subscribe
Spain 2174838 ➤ Subscribe
Israel 103383 ➤ Subscribe
Japan 3614427 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Farmers Insurance
AstraZeneca
Fuji
UBS
Dow
Merck
Federal Trade Commission
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot